当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析

国药股份

(600511)

  

流通市值:164.34亿  总市值:224.09亿
流通股本:5.53亿   总股本:7.55亿

国药股份(600511)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润15.56亿元,每股收益1.98元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1993072.06万元,未分配利润1427884.12万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3512516.12万元,负债1519444.06万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入39,381,301,380.2725,633,950,652.4612,713,002,292.3850,597,449,788.57
营业总成本37,808,187,653.7624,641,402,034.1112,193,672,811.3848,403,886,743.93
其他经营收益
营业利润1,945,535,747.921,229,118,756.21600,659,751.032,677,421,914.45
利润总额1,933,742,465.131,226,579,932.03605,877,265.632,653,612,391.5
净利润1,555,894,465.78991,483,406.86485,061,196.662,129,780,565.04
每股收益
其他综合收益25,861,163.15337,686.56-84,421.65-3,461,287.34
综合收益总额1,581,755,628.93991,821,093.42484,976,775.012,126,319,277.7
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计30,528,913,480.0330,259,719,678.3330,442,472,468.1430,356,823,125.08
非流动资产:
非流动资产合计4,596,247,754.964,538,577,861.624,653,998,605.554,571,456,118.54
资产总计35,125,161,234.9934,798,297,539.9535,096,471,073.6934,928,279,243.62
流动负债:
流动负债合计14,200,537,627.2314,382,535,357.6714,549,466,568.7614,855,742,064.94
非流动负债:
非流动负债合计993,902,979.981,071,518,759.231,086,984,438.91,097,493,887.66
负债合计15,194,440,607.2115,454,054,116.915,636,451,007.6615,953,235,952.6
所有者权益(或股东权益):
归属于母公司股东权益合计18,042,614,851.3417,473,373,453.0117,587,021,750.3917,128,090,785.52
股东权益合计19,930,720,627.7819,344,243,423.0519,460,020,066.0318,975,043,291.02
负债和股东权益合计35,125,161,234.9934,798,297,539.9535,096,471,073.6934,928,279,243.62
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计40,190,830,933.2326,101,716,608.6812,108,689,860.4655,348,362,559.99
经营活动现金流出小计42,241,263,715.3427,612,151,445.4814,001,865,579.3653,689,243,036.17
经营活动产生的现金流量净额-2,050,432,782.11-1,510,434,836.8-1,893,175,718.91,659,119,523.82
投资活动产生的现金流量:
投资活动现金流入小计32,545,348.4732,502,299.843,174,950.6447,062,295.48
投资活动现金流出小计40,419,863.9420,579,477.27,353,156.132,630,772,379.16
投资活动产生的现金流量净额-7,874,515.4711,922,822.64-4,178,205.49-2,583,710,083.68
筹资活动产生的现金流量:
筹资活动现金流入小计319,447,721.2160,000,000100,000,000315,981,517.06
筹资活动现金流出小计1,395,528,475.21,131,724,433.65226,533,020.571,898,314,943.41
筹资活动产生的现金流量净额-1,076,080,754-971,724,433.65-126,533,020.57-1,582,333,426.35
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-3,134,388,051.58-2,470,236,447.81-2,023,886,944.96-2,506,923,986.21
期末现金及现金等价物余额5,157,006,005.385,821,157,609.156,267,507,1128,291,394,056.96
补充资料:
现金及现金等价物的净增加额--2,470,236,447.81--2,506,923,986.21
最新报告期:2025-10-21
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,孔垂岩,王殷杰2.682.812.942025-10-21
中信建投刘若飞,贺菊颖2.682.853.042025-09-05
华福证券何展聪,陈铁林2.712.883.072025-08-26
华源证券刘闯2.712.873.032025-08-25
中金公司夏璐,张琎,朱言音2.702.88--2025-08-21
TOP↑